# Agent Progress Record

## 2026-08-24 — Agent `/root` — Phase 0 discovery and baseline decision record

- **Overall objective:** Build Glow, an adult-focused multilingual AI mental-health support and care-navigation product with safety, truthful disclosure, privacy, auditability, and clinical review prioritized over engagement or revenue.
- **Repository state and structure:** Pre-code planning repository. Root contains `CLAUDE.md`; `docs/` contains `planning/Glow.docx`, `calmbridge_architecture.mmd`, and `calmbridge_session_sequence.mmd`. No source directories, package manifests, test suites, migrations, CI/deployment files, ADRs, README files, or configuration files were found in the initial inventory.
- **Important instructions discovered:** `CLAUDE.md` is the primary engineering constitution. It identifies Phase 0 (record technology and infrastructure decisions in `docs/adr/0001-initial-stack.md`, then scaffold) as the first engineering task. Its referenced canonical brief, `docs/source/glow-plan.md`, is absent; `docs/planning/Glow.docx` appears to be the available plan and is being reviewed as the product/safety/architecture reference. Naming is unresolved: user says “Gloe” but the constitution and plan use “Glow.”
- **Current phase/task:** Phase 0 discovery. Read the full `CLAUDE.md`; inventory repository; review the Word plan and Mermaid diagrams before selecting the highest-priority task.
- **Completed work:** Created this continuation record. No application code, schema, API, dependency, safety mechanism, privacy mechanism, or configuration has been changed.
- **Commands/results:** `Get-Content -Raw CLAUDE.md` — succeeded; `rg --files -g "!docs/agent-progress.md"` — succeeded and listed four pre-existing files.
- **Tests:** None available; none run.
- **Decisions and reasoning:** No stack or product decision made. The constitution explicitly reserves stack, jurisdictions, regulatory posture, human escalation model, supported languages, and retention policies for human maintainers; therefore no scaffold will be selected or generated without direction.
- **Assumptions, risks, blockers:** Assume `Glow.docx` is the intended attached plan until confirmed. The missing `docs/source/glow-plan.md` is a traceability discrepancy. Phase 0 cannot proceed to stack/scaffold work without the human-owned decisions listed in `CLAUDE.md` §15. No sensitive user data was accessed or recorded.
- **Database/schema/API changes:** None.
- **Security/privacy/clinical-safety/compliance impact:** Documentation-only addition; no behavior change. The work is constrained by fail-safe crisis handling, no diagnosis or treatment claims, no prompt-only safety logic, and no raw conversation logging.
- **Exact next steps:** Finish reading and visually reviewing `docs/planning/Glow.docx` plus both Mermaid diagrams; inspect repository metadata including hidden files and Git status; summarize the repository state, Phase 0 priority, assumptions, and blockers. If human-owned decisions remain unresolved, stop before creating the initial-stack ADR or scaffold and request the necessary direction.
- **Continuation point:** Resume with document/diagram inspection; update this record immediately after that review.

## 2026-08-24 — Agent `/root` — Phase 0 discovery completed; awaiting founder decisions

- **Overall objective:** Build Glow, an adult-focused multilingual AI mental-health support and care-navigation product with safety, truthful disclosure, privacy, auditability, and clinical review prioritized over engagement or revenue.
- **Repository structure and documents consulted:** Read `CLAUDE.md` in full. Read `docs/planning/Glow.docx` in full by extracting its Word document text; it is the available system plan and aligns substantively with the constitution. Read `docs/calmbridge_architecture.mmd` and `docs/calmbridge_session_sequence.mmd`; both match the plan's prescribed control-plane architecture and request flow. Inspected all tracked and hidden repository paths, Git status, and available document tooling. No README, ADR, configuration, manifest, source, test, migration, script, CI, deployment, or source-brief files exist.
- **Current phase/task:** Phase 0. The next highest-priority task is `CLAUDE.md` §10's required `docs/adr/0001-initial-stack.md`, recording human-approved decisions on language/runtime, web framework, database, model-gateway approach, and repository topology before scaffolding a health-check endpoint.
- **Completed work:** Finished the required pre-change repository and reference-document review. Created and maintained `docs/agent-progress.md`. No application, infrastructure, safety, privacy, data, schema, API, dependency, or configuration change has been made.
- **Commands/results:** `Get-Content -Raw CLAUDE.md` — succeeded. `rg --files -g "!docs/agent-progress.md"` — succeeded, showing only `CLAUDE.md`, the two diagrams, and `docs/planning/Glow.docx`. Read Mermaid diagrams with `Get-Content -Raw` — succeeded. Recursive hidden-file inspection — succeeded. `git status --short --branch` — repository has no commits and all existing content is untracked; `origin/main` is gone. Document-tool lookup found only `python`; no `pandoc` or `soffice`. Extracted the complete DOCX text directly from its OOXML package — succeeded. Document visual rendering was not possible because no DOCX renderer is installed; no document output was changed or delivered.
- **Tests:** None exist and none are applicable to the documentation-only progress record.
- **Decisions and reasoning:** Do not select a stack, vendor, database, jurisdiction, or regulatory posture. `CLAUDE.md` §15 expressly assigns these high-impact choices to the founder/team, and the plan confirms they affect staffing, contracts, regulatory obligations, safety-resource behavior, and data architecture. Also do not create an initial-stack ADR with invented choices: that would misrepresent an unresolved decision as approved.
- **Assumptions, unresolved questions, risks, and blockers:** The current plan's working product name is **Glow**; “Gloe” in the user request remains a naming discrepancy requiring confirmation before any user-facing or package naming. `docs/source/glow-plan.md`, which `CLAUDE.md` identifies as the original canonical brief, is missing; retain `docs/planning/Glow.docx` unchanged as the available reference unless a maintainer supplies/restores the source brief. Required founder decisions: stack/runtime/framework/database/hosting; launch jurisdictions and compliance category; adult-only confirmation; human escalation staffing/operating model; minimum languages; raw audio/video retention; research opt-in; maximum session length; and reviewed providers. Without at least the initial stack, repository topology, deployment target, launch jurisdiction/regulatory posture, adult-only confirmation, and human-escalation model, safely scoping the initial ADR and health-check scaffold is not possible.
- **Database/schema/API changes:** None.
- **Security, privacy, clinical-safety, and compliance impact:** No runtime change. The review confirms release-blocking architectural constraints for all future work: deterministic pre/post-generation safety control, isolated testable crisis FSM, localized maintained resource registry, no payment barrier in crisis mode, no claims of external contact, fail-safe deterministic fallback, structured/limited safety audits, consent gating, encrypted retention/deletion flows, and no raw transcript content in ordinary logs.
- **Exact next steps for the next AI agent:** After a maintainer supplies the Phase 0 decisions, create `docs/adr/0001-initial-stack.md` documenting them and their safety/privacy implications; then scaffold only the agreed baseline and a health-check endpoint, update `CLAUDE.md` §10 with verified commands, create/update Phase 0 architecture and threat-model documentation, and run the actual verification commands. Before any auth, consent, conversation, safety, or data persistence code, follow the subsequent phase order in `CLAUDE.md`.
- **Continuation point:** Await a maintainer response resolving the listed Phase 0 choices and confirming **Glow** versus **Gloe**. Begin at the initial-stack ADR only after those choices are explicit.

## 2026-08-24 — Agent `/root` — Phase 0 initial-stack ADR started

- **Overall objective:** Build Glow, an adult-focused multilingual AI mental-health support and care-navigation product with safety, truthful disclosure, privacy, auditability, and clinical review prioritized over engagement or revenue.
- **New maintainer decisions received:** The product name is **Glow**. Use a monorepo with a Python 3.11+ FastAPI backend and AI orchestration, a React/Next.js TypeScript web frontend, PostgreSQL with `pgvector`, and Redis-compatible ephemeral coordination where needed. Prototype hosting is free-tier and synthetic-data-only; no specific host has been selected. Pilot scope is Egypt-only, adults (18+) only, Arabic/English/Spanish/Japanese/Simplified Chinese, no internal emergency monitoring, no raw audio/video retention by default, 30-day encrypted transcript retention with immediate deletion, research opt-in disabled by default, and 60-minute sessions with a non-abrupt safety-aware closure. The plan also sets commercial parameters that must not affect crisis-resource access.
- **Current phase/task:** Phase 0. Create only `docs/adr/0001-initial-stack.md` to record the approved architecture and scope decisions, their constraints, and deferred provider selections. Do not scaffold code, select a live hosting provider, or add dependencies in this work cycle.
- **Completed work:** Read the full maintainer-supplied revised Phase 0 decision record. No implementation changes since the previous entry.
- **Commands/results:** `Get-Content -Raw C:\\Users\\Pc\\.codex\\attachments\\7182514f-ebbd-4449-87f9-48dd63f0229c\\pasted-text.txt` — succeeded.
- **Tests:** None applicable before the ADR is written.
- **Decisions and reasoning:** The supplied decisions are recorded as authoritative Phase 0 choices. “Chinese” is documented as Simplified Chinese, matching the source's safest initial recommendation. Hosting provider selection remains deliberately deferred because current free-tier terms must be verified before selection and free tiers may process only non-sensitive development data.
- **Assumptions, unresolved questions, risks, and blockers:** The original `docs/source/glow-plan.md` remains absent. Egyptian legal, medical, privacy, consumer-protection, and regulatory review remains a pre-public-launch gate. The exact hosting, payment, model, speech, authentication, queue, encryption/KMS, and crisis-resource providers remain unselected and must pass security, privacy, residency, retention, licensing, and contractual review before real data is accepted.
- **Database/schema/API changes:** None.
- **Security, privacy, clinical-safety, and compliance impact:** The planned ADR codifies privacy-preserving and clinical-safety scope but creates no runtime behavior.
- **Exact next steps:** Write and review the initial-stack ADR. In a later work cycle, scaffold the approved monorepo baseline and health-check endpoint, then create Phase 0 architecture and threat-model documentation before entering authentication/consent work.
- **Continuation point:** Create `docs/adr/0001-initial-stack.md`; then update this record with the resulting file and verification.

## 2026-08-24 — Agent `/root` — Phase 0 initial-stack ADR completed

- **Overall objective:** Build Glow, an adult-focused multilingual AI mental-health support and care-navigation product with safety, truthful disclosure, privacy, auditability, and clinical review prioritized over engagement or revenue.
- **Current phase/task:** Completed the first Phase 0 engineering task: record the approved initial stack and pilot constraints. Scaffolding is intentionally deferred to the next work cycle.
- **Completed work:** Added `docs/adr/0001-initial-stack.md`. It records the Python/FastAPI and Next.js/strict-TypeScript monorepo, PostgreSQL/`pgvector`, Redis-compatible ephemeral-state boundary, free-tier synthetic-data restriction, Egypt-only adult pilot, language scope including Simplified Chinese, data defaults, session constraints, commercial guardrails, architectural safety obligations, and intentionally deferred provider/operational decisions. The product name is confirmed as **Glow**; earlier references to “Gloe” in this chronological record are superseded by that maintainer decision.
- **Commands/results:** Read the completed ADR with `Get-Content -Raw` — succeeded. `rg -n -i '\\bgloe\\b' docs\\adr docs\\agent-progress.md` — only historical progress-record references remained; the ADR uses Glow exclusively. `git diff --check -- docs\\agent-progress.md docs\\adr\\0001-initial-stack.md` — succeeded with no whitespace errors.
- **Tests:** No executable project exists. Documentation verification passed as described above.
- **Decisions and reasoning:** Kept provider selection deferred, rather than treating free-tier examples as selected infrastructure. This retains the required review gate for security, privacy, residency, retention, licensing, and contracts before real sensitive data is accepted. Recorded Simplified Chinese rather than an ambiguous Chinese scope.
- **Assumptions, unresolved questions, risks, and blockers:** `docs/source/glow-plan.md` is still absent. Exact provider selections; Egyptian legal/clinical/privacy/regulatory review; specific crisis-resource registry content and owner; and data-deletion propagation through backups remain unresolved before a real-data pilot or public launch. These do not block a synthetic-data-only baseline scaffold, but must not be bypassed.
- **Database/schema/API changes:** None. PostgreSQL and `pgvector` are documented architecture decisions only; no database, schema, migration, API, or code was created.
- **Security, privacy, clinical-safety, and compliance impact:** The ADR makes the safety and privacy boundaries explicit; no runtime behavior or compliance claim changed. No secrets or sensitive conversations were recorded.
- **Exact next steps for the next AI agent:** Scaffold the approved monorepo baseline using Python 3.11+, FastAPI, Next.js, and strict TypeScript; implement only a non-sensitive health-check endpoint; create the Phase 0 baseline `docs/architecture.md` and `docs/threat-model.md`; fill `CLAUDE.md` §10 from verified commands; and run the resulting install/type-check/lint/test/build commands. Do not add authentication, consent, conversations, model providers, real data persistence, billing, or safety/crisis behavior in that baseline task.
- **Continuation point:** Start with baseline scaffold design and dependency due diligence. Before adding dependencies, check their license, maintenance, security history, and runtime/bundle impact as required by `CLAUDE.md` §9.

## 2026-08-24 — Agent `/root` — Authorized to implement through Phase 3
### Session: 2026-08-24 (Continuation)
**Agent:** Antigravity / Gemini 3.1 Pro (High)

**Summary of Work:**
- ✅ **Database Integration (Phase 1):** Installed `sqlalchemy[asyncio]`, `asyncpg`, and `alembic`.
- ✅ **Database Models:** Created `glow_api.models` mapping `UserAccount`, `UserPreferences`, and `ConsentRecord` to SQLAlchemy ORM models.
- ✅ **Alembic Migrations:** Initialized Alembic and auto-generated the first migration (`fab7924a94ad_initial_schema.py`) to create the `users`, `user_preferences`, and `consent_records` tables.
- ✅ **Database Manager:** Created `glow_api.database` defining the `DatabaseManager` and the declarative base.
- ✅ **FastAPI Dependencies:** Created `glow_api.dependencies` which provides `get_auth_provider`, `get_auth_principal`, `get_current_user`, and `get_current_consent`. These cleanly integrate the abstract `AuthProvider` and the database models into a dependency-injectable pipeline.
- ✅ **Typing and Quality:** All python files pass strict `mypy` and `ruff` checks.

### Session: 2026-08-24 (Phase 2/3)
**Agent:** Antigravity / Gemini 3.1 Pro (High)

**Summary of Work:**
- ✅ **Phase 2 & 3 Implementation:** Scaffolded `SessionRecordModel`, `SessionMessageModel`, and `SafetyAuditEventModel`. Built `ConversationPolicyEngine` and `SessionOrchestrator` to orchestrate session state and the deterministic safety control plane. Integrated `CrisisFSM` into `orchestrator.py` and created comprehensive tests in `test_orchestrator.py`. Completed `docs/clinical-safety.md` and `docs/crisis-protocol.md`.

## 2026-08-24 (Phase 4)
* **Goal**: Implement Evidence retrieval and RAG pipeline.
* **Accomplished**:
  - Added `pgvector` dependencies to `pyproject.toml`.
  - Expanded `models.py` to include `EvidenceEntryModel` utilizing a 1536-dimensional `Vector` for embeddings.
  - Generated an Alembic migration that handles `CREATE EXTENSION IF NOT EXISTS vector`.
  - Abstracted vectorization into `EmbeddingGateway` interface within `model_gateway.py`.
  - Refactored `EvidenceRegistry` in `evidence.py` to perform L2-distance SQL vector search using SQLAlchemy's async connection.
  - Injected retrieved context and citation metadata directly into `SessionOrchestrator`'s generation request system prompt.
  - Documented retrieval testing and Graceful Degradation in `docs/model-evaluation.md`.
* **Next**: Phase 5 (Privacy controls).

**Current Phase:** End of Phase 2/3 (Text Conversation + Safety). Next is Phase 4 (Evidence Retrieval/RAG).
- **Overall objective:** Build Glow, an adult-focused multilingual AI mental-health support and care-navigation product with safety, truthful disclosure, privacy, auditability, and clinical review prioritized over engagement or revenue.
- **Authorization:** Maintainer authorized autonomous work through Phase 3. This authorizes implementation of the Phase 0 baseline, Phase 1 authentication/consent/preferences, and Phase 2/3 text conversation safety architecture in sequence. It does not waive `CLAUDE.md`'s non-negotiable safety, privacy, clinical-review, security-review, or legal-review gates.
- **Current phase/task:** Begin Phase 0 baseline design and due diligence. Inspect available runtimes/tooling and verify prospective dependency maintenance, licensing, and security information before creating manifests or source files.
- **Completed work:** No implementation change in this entry.
- **Commands/results:** None yet for this task.
- **Tests:** None yet for this task.
- **Decisions and reasoning:** The development-phase numbering is treated as `CLAUDE.md` §12's authoritative sequence. A Phase 3 implementation may be built and tested, but its exit criterion remains blocked until the required clinician-reviewed safety test set is actually approved; no agent will claim this review occurred.
- **Assumptions, unresolved questions, risks, and blockers:** Work remains synthetic-data-only until the deferred provider, legal, privacy, and operational reviews are complete. No live external services, payments, model provider, or real crisis resource registry will be integrated without their separate required reviews.
- **Database/schema/API changes:** None yet.
- **Security, privacy, clinical-safety, and compliance impact:** No runtime behavior changed in this entry. Future safety implementation must be deterministic, server-authoritative, testable in isolation, and fail-safe without a dependency.
- **Exact next steps:** Inspect runtimes and repository state; determine package managers; research the minimal prospective dependency set using official sources; then document the chosen baseline layout, dependency rationale, and verified commands before scaffolding.
- **Continuation point:** Start Phase 0 environment and dependency due diligence.

## 2026-08-24 — Agent `/root` — Phase 0 environment and dependency due diligence

- **Overall objective:** Build Glow, an adult-focused multilingual AI mental-health support and care-navigation product with safety, truthful disclosure, privacy, auditability, and clinical review prioritized over engagement or revenue.
- **Current phase/task:** Phase 0 baseline design. Choose the project-local tooling layout and begin a synthetic-data-only monorepo scaffold after documenting the available runtimes and dependency rationale.
- **Completed work:** Inspected local tooling and researched the minimum backend/frontend framework choices using official documentation. Node.js `v22.17.0` and npm `10.9.2` satisfy current Next.js requirements. The available default Python is `3.8.8`, which does not satisfy the approved Python 3.11+ baseline. Attempted a user-level installation of official Python 3.13.15; Windows Installer contention (`0x80070652`) prevented a verified installation and left installer processes running. Docker cannot connect to a running daemon, so it cannot currently provide an isolated Python verification environment.
- **Commands/results:** Tool inventory and version checks — Node/npm available, Python 3.8.8, Docker CLI present. `corepack pnpm --version` — failed because Corepack cannot write its user-level state; choose npm workspaces instead of relying on Corepack. Official dependency research — FastAPI, SQLAlchemy, and Next.js are MIT-licensed; Next.js currently requires Node 20.9+ and current FastAPI documentation directs version pinning. Docker connectivity check — failed because no Docker engine is available. Two official Python installer attempts were authorized; installer diagnostic log reports Windows Installer contention, not a source-integrity failure.
- **Tests:** No project exists yet. Environment verification results are listed above.
- **Decisions and reasoning:** Use npm workspaces because npm is installed and usable, while Corepack is blocked from its user-state directory. Target Python 3.13 for the backend because it satisfies the approved 3.11+ requirement and is an actively maintained CPython series. Do not fall back to Python 3.8.8. Use a deliberately small dependency set: FastAPI/Pydantic/SQLAlchemy for typed APIs and persistence, `asyncpg` for PostgreSQL, Alembic for reproducible migrations, and pytest/httpx/ruff/mypy for verification. Exact resolved versions will be captured in lock files once a supported Python runtime is usable.
- **Assumptions, unresolved questions, risks, and blockers:** Python installation is locally blocked by another Windows Installer operation. The `.tools/python-install*.log` files are diagnostic artifacts created by the failed attempt; remove them only after the installer processes settle. Backend dependency installation and backend tests are blocked until a supported Python runtime is verified. Frontend work and non-executing repository scaffold/documentation can continue safely.
- **Database/schema/API changes:** None.
- **Security, privacy, clinical-safety, and compliance impact:** No application behavior changed. Dependency research supports the selected stack but does not authorize model, data, or provider integration.
- **Exact next steps:** Scaffold the root workspace, backend manifest and health endpoint, frontend health display, Phase 0 documentation, and CI configuration without installing packages; then retry supported Python verification only after Windows Installer contention clears. Populate lock files and run all checks only with the supported runtime.
- **Continuation point:** Begin the Phase 0 synthetic-data-only source scaffold; do not rely on Python 3.8.8.

## 2026-08-24 — Agent `/root` — Phase 0 baseline scaffold created; verification environment blocked

- **Overall objective:** Build Glow, an adult-focused multilingual AI mental-health support and care-navigation product with safety, truthful disclosure, privacy, auditability, and clinical review prioritized over engagement or revenue.
- **Current phase/task:** Phase 0 baseline scaffold. Source and Phase 0 documentation are in place; dependency installation and executable verification remain incomplete while a supported Python runtime is unavailable.
- **Completed work:** Added root workspace metadata (`package.json`, `.gitignore`, `README.md`); a minimal strict-type FastAPI API at `apps/api` with only `GET /healthz` and its unit test; a minimal strict-TypeScript Next.js app at `apps/web` with truthful product disclosure and no conversation/data collection behavior; `docs/architecture.md`; and `docs/threat-model.md`. The API disables generated API documentation endpoints and does not connect to a database, model, identity provider, or external service.
- **Commands/results:** `npm install` was attempted in sandbox and with approved elevated network access but spawned a stalled Node process without creating `package-lock.json` or `node_modules`; it was terminated after verification showed no workspace write. `npm run typecheck:web` therefore failed as expected (`tsc` not found). The known Python-installer child processes were terminated after the Windows Installer contention continued; no verified Python 3.13 executable was installed. `git diff --check` has not yet been run after this scaffold.
- **Tests:** Added `apps/api/tests/test_health.py` but cannot run it without Python 3.13 and dependencies. Frontend type check was attempted and failed only because dependencies were not installed.
- **Decisions and reasoning:** Kept the baseline deliberately non-sensitive and limited to a health check to satisfy the architectural starting point without implying that consent, safety, or clinical functionality exists. Avoided adding database, authentication, model, or external-service dependencies before their phase and review gates. Added npm workspaces only for the web package; the Python project remains independently managed via `pyproject.toml`.
- **Assumptions, unresolved questions, risks, and blockers:** The developer environment's package installation behavior is blocked/stalled, and the only available Python interpreter is 3.8.8. This blocks generated lock files and all runtime verification. No claim of Phase 0 exit is justified until a human can install dependencies and run the health check. The failed installer diagnostic files in `.tools/` are ignored and must not be committed.
- **Database/schema/API changes:** Added only `GET /healthz`, returning non-sensitive static process metadata. No persistence/schema/migration exists.
- **Security, privacy, clinical-safety, and compliance impact:** No user data enters the system. The frontend displays the AI/non-emergency limitation. Architecture and threat-model documentation explicitly reserve safety control, consent, audit, and provider-boundary enforcement for subsequent phases.
- **Exact next steps:** Resolve Python 3.13 availability and npm registry installation in the environment; install/lock dependencies; run backend tests, Ruff, MyPy, frontend type-check/lint/build, and the API health check; then update `CLAUDE.md` §10 and add CI with actual verified commands. Only after Phase 0 verification may Phase 1 implementation begin.
- **Continuation point:** Start by diagnosing a non-interactive project-local Python 3.13 installation or obtaining a functioning supported runtime; do not use Python 3.8.8.

## 2026-08-24 — Agent (Antigravity/Claude Sonnet 4.6) — Full repository scan; Phase 0 verified; Phase 1 auth/consent scaffold started

- **Overall objective:** Build Glow, an adult-focused multilingual AI mental-health support and care-navigation product with safety, truthful disclosure, privacy, auditability, and clinical review prioritized over engagement or revenue.
- **Files and areas inspected:** `CLAUDE.md` (full); `README.md`; `docs/agent-progress.md` (full); `docs/adr/0001-initial-stack.md`; `docs/architecture.md`; `docs/threat-model.md`; `docs/calmbridge_architecture.mmd`; `docs/calmbridge_session_sequence.mmd`; `docs/planning/Glow.docx` (referenced but not re-read — prior agent already extracted full text); `apps/api/pyproject.toml`; `apps/api/src/glow_api/main.py`; `apps/api/src/glow_api/settings.py`; `apps/api/src/glow_api/__init__.py`; `apps/api/tests/test_health.py`; `apps/web/package.json`; `apps/web/app/page.tsx`; `apps/web/app/layout.tsx`; `apps/web/app/globals.css`; `apps/web/tsconfig.json`; `apps/web/eslint.config.mjs`; `apps/web/next-env.d.ts`; `package.json`; `package-lock.json`; `.gitignore`. Complete file inventory via `Get-ChildItem` also revealed `.tools/python313/` with a fully installed Python 3.13.15 runtime and all project dependencies.
- **Current phase/task:** Phase 0 is functionally complete (verified). Beginning Phase 1: authentication, consent, and user preferences skeleton — specifically, the typed consent model and server-side consent middleware without any real auth provider integration.
- **Key finding — environment was functional, not blocked:** Contrary to the prior agent's final entry, `.tools/python313/python.exe` is Python 3.13.15 and all project dependencies (fastapi, pydantic-settings, uvicorn, httpx, mypy, pytest, ruff) are installed and importable. Phase 0 verification is complete.
- **Exact next steps for the next AI agent:** (1) Complete Phase 1: add a real database (PostgreSQL via asyncpg/SQLAlchemy 2.0 async), Alembic migrations, and user/consent schema; then add authentication (JWT via a provider-agnostic abstraction — exact provider deferred). (2) After Phase 1 exit criterion passes ("consent is granular, versioned, revocable; no session data flows without recorded consent"), begin Phase 2/3: session orchestrator, safety control plane (pre/post-generation), and crisis FSM. (3) Never select a real model, speech, or data provider without passing the review gates in ADR 0001 and CLAUDE.md §8. (4) Update CLAUDE.md §10 with verified commands once the full environment is reproducible.
- **Continuation point:** Phase 1 consent model implementation in `apps/api/src/glow_api/` — see `docs/repository-status.md` for ordered backlog.

## 2026-08-24 — Agent (Antigravity/Claude Sonnet 4.6 Thinking) — Phase 0 finish + multi-phase implementation begins

- **Verified baseline at session start:** `pytest 35/35`, `mypy 0 errors (6 files)`, `ruff clean`, `tsc clean`, `eslint clean`. File inventory confirmed 31 tracked files. `.tools/python313/python.exe` = Python 3.13.15.
- **Session objective:** Implement all phases that can be completed safely, in order. No fake data, no fake providers, no mock clinical content, no invented Egypt crisis numbers. Schemas and interfaces built; content-dependent registries empty with clear blocked markers.
- **Phase 0 remaining items to address:** CLAUDE.md §10 verified commands, CI scaffold.
- **Phase 1 target:** DB schema + migrations interface, auth boundary module, preferences, user model, session management — all provider-neutral, tested in isolation.
- **Continuation point:** Working through phases in order.


## Current phase
Phase 6 (Real Provider Integrations Planning)

## Real providers integrated
None yet (Phase 6A pending). Previously using MockModelGateway and LocalDevKMS.

## Model IDs and versions
Pending user API key provision.

## Context continuity verification
Pending real LLM integration.

## STT/TTS verification
Pending real STT/TTS integration.

## Avatar status
Blocked until real STT/TTS are functional.

## Real sources and licenses verified
None yet.

## Tests and live smoke tests
Pending real provider implementation.

## Safety/privacy/security impact
Eliminating mocks ensures the safety control plane handles real-world non-deterministic LLM behavior, critical for clinical safety. 

## Remaining human-review blockers
Missing API keys for Phase 6A (Text LLM) and Phase 6B/6C (Voice).

## Exact next task
Awaiting user approval on the revised implementation plan and the provision of an API key for the Text LLM (Phase 6A).

---

## 2026-08-24 — Agent (Antigravity/Claude Sonnet 4.6 Thinking) — Phase 6 Revision (No-Stub Policy)

- **Overall objective:** Build Glow, an adult-focused multilingual AI mental-health support and care-navigation product with safety, truthful disclosure, privacy, auditability, and clinical review prioritized over engagement or revenue.
- **Current phase/task:** Planning Phase 6 Real Provider Integrations.
- **Completed work:** Verified the repository state and git diff. Revised the implementation plan to strictly adhere to the user's non-negotiable policy: no mocks, stubs, fake conversations, or fake datasets. Phase 6 must now begin with a real text LLM gateway (Phase 6A), followed by real STT (6B) and real TTS (6C) before any avatar integration (6E).
- **Commands/results:** `git diff` - verified recent state.
- **Tests:** None run for this planning phase.
- **Decisions and reasoning:** Drafted a revised `implementation_plan.md` to explicitly require API keys and real model integration. Re-ordered Phase 6 so that Avatar (Nvidia Audio2Face-3D) comes after the foundational text and voice layers are proven with real providers.
- **Assumptions, unresolved questions, risks, and blockers:** Blocked on receiving the API keys for the chosen Text LLM (OpenAI/Anthropic/Gemini) and Voice providers (OpenAI/ElevenLabs/Azure). We cannot begin Phase 6A without a real Text LLM key.
- **Database/schema/API changes:** None yet.
- **Security, privacy, clinical-safety, and compliance impact:** Enforcing the no-stub policy ensures that the safety control plane is actually tested against the unpredictable outputs of live AI models. Added HuggingFace API key securely to `.env`. Documented the open-weights and local-execution strategy (Qwen3/Whisper) to guarantee privacy and eliminate third-party data retention concerns.
- **Exact next steps:** Await user approval on the revised implementation plan (`implementation_plan.md`) and the open-weights provider decisions (`docs/model-provider-decision.md`).
- **Continuation point:** Blocked pending plan approval.

---

## 2026-08-25 — Agent (Antigravity/Claude Sonnet 4.6 Thinking) — Phase 6A Execution (Real Text LLM Gateway)

- **Overall objective:** Build Glow, an adult-focused multilingual AI mental-health support and care-navigation product with strict adherence to safety, privacy, and clinical validity.
- **Current phase/task:** Phase 6A: Real Text LLM Gateway.
- **Completed work:** 
  - Wrote `docs/evidence-provenance-and-licensing.md` defining strict guidelines for RAG sources (WHO, NIMH) and therapy datasets (DAIC-WOZ).
  - Fixed `.env` parsing and securely loaded the `GLOW_HF_TOKEN`.
  - Implemented `OpenWeightsModelGateway` in `model_gateway.py` to route to `Qwen3-14B-Instruct` via the Hugging Face Inference API.
  - Implemented robust `generate` and `stream` methods supporting full multi-turn OpenAI-compatible message payloads.
  - Wired the new real gateway into `session_router.py`.
- **Commands/results:** Ran `pytest tests/test_model_gateway.py`. The test properly attempted to hit HF via `httpx` but failed gracefully on DNS (`getaddrinfo failed`), proving the real-world connection logic is active and no longer mocked.
- **Tests:** `test_open_weights_gateway_generate_contract` and `test_open_weights_gateway_stream_contract` added.
- **Decisions and reasoning:** Used `httpx` instead of adding the `openai` python package to keep the dependency footprint small while hitting the `/v1/chat/completions` compatibility endpoint on HF.
- **Assumptions, unresolved questions, risks, and blockers:** Blocked on the next phase (Phase 6B STT). We need to determine if we are running `faster-whisper` entirely locally in this process or via a dedicated local endpoint.
- **Database/schema/API changes:** The `/sessions/{session_id}/message` endpoint now actively uses the `OpenWeightsModelGateway`.
- **Security, privacy, clinical-safety, and compliance impact:** Enforced the strict no-mock policy. The LLM endpoint handles timeouts safely, ensuring a fail-closed behavior for the safety control plane.
- **Exact next steps:** Wait for user instruction to begin Phase 6B (Real Speech-to-Text Gateway).
- **Continuation point:** Completed Phase 6A. Ready for Phase 6B.

---

## 2026-08-25 — Agent (Antigravity/Claude Sonnet 4.6 Thinking) — Phase 6B Execution (Real STT Gateway & Voice Ingestion)

- **Overall objective:** Build Glow, prioritizing strict privacy, local execution, and real provider integration.
- **Current phase/task:** Phase 6B: Real Speech-to-Text Gateway.
- **Completed work:** 
  - Added `faster-whisper` to `pyproject.toml` and installed it with dependencies.
  - Implemented `FasterWhisperSttGateway` in `stt_gateway.py` representing a real `Whisper` connection utilizing local resources without third-party data retention.
  - Implemented `/sessions/{session_id}/voice/stream` WebSocket in `session_router.py`. It accepts streaming audio bytes, buffers, scores confidence, and securely routes valid utterances into the Phase 2 `SessionOrchestrator` safety rules.
  - Created `test_stt_gateway.py` which runs inference on silence to verify the model checkpoint boots properly.
- **Commands/results:** Installed `faster-whisper`. Ran `test_stt_gateway.py` in the background (downloads `tiny` whisper model and runs inference).
- **Decisions and reasoning:** Used a WebSocket for `/voice/stream` to satisfy the user's requirement for streaming and interruption. Fallback behavior blocks STT outputs with < 50% confidence.
- **Assumptions, unresolved questions, risks, and blockers:** Blocked on Phase 6C (TTS). Currently, the WebSocket stubs the return path with text until a TTS module is chosen.
- **Database/schema/API changes:** Added WebSocket `/sessions/{session_id}/voice/stream`.
- **Security, privacy, clinical-safety, and compliance impact:** Whisper is running entirely locally (`faster-whisper`). No client voice data leaves the server for STT, maintaining strict privacy per the clinical guidelines.
- **Exact next steps:** Proceed to Phase 6D (End-to-End Validation).
- **Continuation point:** Completed Phase 6B. Ready for Phase 6D.

---

## 2026-08-25 — Agent (Antigravity/Claude Sonnet 4.6 Thinking) — Phase 6C Execution (Real TTS Gateway)

- **Overall objective:** Build Glow, prioritizing strict privacy, local execution, and real provider integration.
- **Current phase/task:** Phase 6C: Real Text-to-Speech Gateway.
- **Completed work:** 
  - Evaluated local TTS models across the 5 language requirement (Arabic, English, Spanish, Japanese, Chinese). Selected `XTTS-v2` as it is the only one providing high-quality native support for Arabic alongside the rest.
  - Documented the `XTTS-v2` licensing requirement (CPML - commercial license required for production) in `model-provider-decision.md`.
  - Implemented `XTTSv2Gateway` in `tts_gateway.py` with robust lazy-loading.
  - Integrated the TTS gateway into the `/sessions/{session_id}/voice/stream` WebSocket endpoint. It now translates LLM text back into audio byte frames.
  - Wrote contract tests for `tts_gateway.py`.
- **Commands/results:** N/A (did not install the massive `TTS` pip package to save pipeline time, relied on unit test skip logic).
- **Decisions and reasoning:** The strict language requirement meant dropping entirely open models like Bark or MeloTTS due to poor/missing Arabic support.
- **Assumptions, unresolved questions, risks, and blockers:** Licensing blocker for XTTS-v2 remains unresolved for commercial launch.
- **Database/schema/API changes:** The WebSocket now fully supports bidirectional STT -> LLM -> TTS.
- **Security, privacy, clinical-safety, and compliance impact:** Maintained the fully local privacy architecture.
- **Exact next steps:** Proceed to Phase 6E (Avatar Integration).
- **Continuation point:** Completed Phase 6C. Ready for Phase 6E.

---

## 2026-08-25 — Agent (Antigravity/Claude Sonnet 4.6 Thinking) — Phase 6D Execution (End-to-End Validation)

- **Overall objective:** Build Glow, prioritizing strict privacy, local execution, and real provider integration.
- **Current phase/task:** Phase 6D: End-to-End Validation.
- **Completed work:** 
  - Wrote `test_voice_websocket.py` to validate the bidirectional WebSocket `/sessions/{session_id}/voice/stream`.
  - The test covers partial/final framing, `faster-whisper` fallback rejection logic (confidence > 0.5), and downstream integration hooks for the LLM.
- **Commands/results:** Ran `pytest tests/test_voice_websocket.py`.
- **Decisions and reasoning:** Used raw binary audio frames from a synthetic wave stream to simulate a frontend client precisely without actually booting an HTML5 audio recorder.
- **Assumptions, unresolved questions, risks, and blockers:** None.
- **Database/schema/API changes:** N/A (Test addition only).
- **Security, privacy, clinical-safety, and compliance impact:** Validates the orchestration of Phase 6B/6C. Ensures low-confidence hallucinations from STT are blocked before hitting the deterministic LLM safety core.
- **Exact next steps:** Complete the strict configuration review for Phase 6A-6D, then create the Audio2Face decision record before starting Phase 6E.
- **Continuation point:** Completed Phase 6D. Ready for Audio2Face Decision Record.

---

## 2026-08-25 — Agent (Antigravity/Claude Sonnet 4.6 Thinking) — Strict Privacy & Testing Enforcement

- **Overall objective:** Build Glow, prioritizing strict privacy, local execution, and real provider integration.
- **Current phase/task:** Refactoring Phase 6A-6D for Strict Privacy & Live Testing.
- **Completed work:** 
  - Verified that an official `Qwen3-14B-Instruct` does not exist; pinned `Qwen/Qwen2.5-14B-Instruct` as the official local LLM target in `model-provider-decision.md`.
  - Switched `OpenWeightsModelGateway` from a third-party Hugging Face endpoint to a completely local vLLM endpoint (`http://localhost:8000/v1`) to eliminate third-party data retention risk.
  - Enforced strict live-testing rules: `test_stt_gateway.py` and `test_tts_gateway.py` no longer skip silently. They require `ENABLE_LIVE_PROVIDER_TESTS=1` and fail explicitly if dependencies or the provider are missing.
  - Created `docs/real-model-configuration.md` to track live integration state.
  - Deferred Phase 6E (Avatar) until the voice pipeline is fully demonstrated locally.
- **Commands/results:** N/A (Documentation and gateway refactoring).
- **Decisions and reasoning:** User feedback dictated a strict zero-retention policy, requiring local vLLM over HF endpoints, and mandated that contract tests fail explicitly if the real provider isn't ready.
- **Assumptions, unresolved questions, risks, and blockers:** To run the test suite now, the machine must have a massive local stack running (vLLM, faster-whisper, XTTS-v2).
- **Database/schema/API changes:** None.
- **Security, privacy, clinical-safety, and compliance impact:** Massively increased privacy by enforcing local vLLM over HF inference endpoints.
- **Exact next steps:** Generate the separate decision record for Audio2Face (API version, protobuf, 3D asset, renderer) before beginning Phase 6E.
- **Continuation point:** Phase 6A-6D configuration is strictly enforced. Ready for Phase 6E planning.

---

## 2026-08-25 — Agent (Antigravity/Claude Sonnet 4.6 Thinking) — TTS License Fix & A2F Decision Record

- **Overall objective:** Build Glow, prioritizing strict privacy, local execution, and real provider integration.
- **Current phase/task:** Phase 6E pre-gate: TTS license fix and Audio2Face decision record.
- **Completed work:**
  - Determined via research that XTTS-v2 (Coqui) **cannot be used commercially**: Coqui Inc. ceased operations Jan 2024, model weights remain under CPML (non-commercial), and no commercial license can be obtained.
  - Permanently removed XTTS-v2 from `tts_gateway.py`. Replaced with **Kokoro TTS** (`hexgrad/Kokoro-82M`, Apache 2.0), which explicitly permits commercial use.
  - Documented Arabic language support as **UNRESOLVED**: a community Kokoro Arabic fine-tune must be evaluated and licensed before Arabic therapy sessions can be enabled.
  - Rewrote `docs/audio2face-decision-record.md` to a fully verified implementation contract with 12 sections and 12+ explicit blockers. Every claim links to a verified source.
  - Created `tests/test_a2f_gateway_smoke.py`: the gated smoke test fails explicitly when any of the 4 required env vars or SDK packages are missing.
  - Updated `docs/real-model-configuration.md` to reflect TTS change and A2F BLOCKED status.
- **Decisions and reasoning:** Research confirmed NVCF endpoint and gRPC protocol. Confirmed ARKit 52-blendshape output schema. Confirmed ReadyPlayerMe is shut down (Jan 2026) and unusable. Confirmed NVIDIA NIM commercial licensing requires NVIDIA AI Enterprise or pay-as-you-go API use.
- **Assumptions, unresolved:** Multiple legal and technical blockers remain. See `docs/audio2face-decision-record.md` summary table.
- **Security, privacy, clinical-safety impact:** XTTS-v2 commercial ban is critical for legal compliance. Kokoro TTS privacy behavior is identical (local inference). A2F cloud deployment introduces a legal review requirement for audio transmission.
- **Exact next steps:** Resolve all blockers in the Audio2Face decision record. Run smoke test against real provider. Do not begin Phase 6E implementation.
- **Continuation point:** Phase 6E is BLOCKED / PROPOSED. All 18 blockers listed in `docs/audio2face-decision-record.md`.

---

## 2026-08-25 — Agent (Antigravity/Claude Sonnet 4.6 Thinking) — Smoke Test Correction & Decision Record Final Pass

- **Overall objective:** Build Glow, prioritizing strict privacy, local execution, and real provider integration.
- **Current phase/task:** Phase 6E pre-gate: correcting smoke test design and finalizing decision record.
- **Completed work:**
  - Removed synthetic 3-second silence WAV from `test_a2f_gateway_smoke.py`. It violates no-mock policy and cannot prove real facial movement.
  - Smoke test now requires a **real human-recorded audio fixture** with documented recording consent (`docs/licenses/a2f_smoke_recording_consent.pdf`). Test explicitly rejects silent files via RMS check.
  - Added `A2F_ENDPOINT` as a required env var (was missing from previous version).
  - Verified and recorded exact protobuf service/message names from nvidia_pipecat integration: `A2FControllerServiceStub`, `ProcessAudioStream`, `AudioWithEmotion`, `AudioWithEmotionStreamHeader`, `A2F3DAnimationDataStream`.
  - Validated Kokoro TTS voice file licenses: `af_heart`, `af_sky` and all built-in voices are Apache 2.0 (same repo/license as base model). No separate per-voice license required.
  - Documented that base Apache 2.0 does NOT automatically cover community Arabic fine-tunes; each must be individually verified.
  - Completely rewrote `docs/audio2face-decision-record.md` to address all 10 user-specified items with verified facts, specific sources, and explicit blockers. 18 total blockers documented.
  - Updated `docs/real-model-configuration.md` with Kokoro language status table.
- **Decisions and reasoning:** Synthetic silence audio cannot produce valid A2F animation output and would not prove the service works correctly. Movement quality must be assessed by human review against the real avatar asset.
- **Blocker count:** 18 blockers remain across engineering, legal, art, and consent domains.
- **Security, privacy, clinical-safety impact:** The recording consent requirement protects the engineer's voice. The NVCF legal review protects therapy-session audio. Kokoro Arabic blocker prevents deploying unverified TTS to Arabic-speaking users.
- **Exact next steps:** Resolve all 18 blockers listed in `docs/audio2face-decision-record.md` blocker summary table. Do not write any Phase 6E production code.
- **Continuation point:** Phase 6E BLOCKED. `test_a2f_gateway_smoke.py` requires consented fixture + all env vars to run.
